Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Worldwide Biosimilars Market Research Report 2021 by Type, Application, Participants and Countries, COVID-19 Impact, Forecast Year to 2026

  • PRO4473548
  • 130 Pages
  • May 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Due to the high popularity of this product/service in North America and Asia, the growth trend of Biosimilars in recent years and the growth of consumers' demand is expected to drive the global Biosimilars market.

Geographically, the global Biosimilars market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.

North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Biosimilars market in North America.

Significant participants active in the global Biosimilars market include: Amgen Inc, Teva Pharmaceutical Industries Ltd., Mylan N.V, Sandoz International GmbH, Dr. Reddy’s Laboratories Ltd., Samsung Bioepis, Biocon, F. Hoffmann-La Roche AG, Pfizer Inc....

Global Biosimilars Market Segmentation:

Biosimilars market, by Biosimilars type:

Human Growth Hormone

Erythropoietin

Monoclonal Antibodies

Insulin

Interferon

Granulocyte-Colony Stimulating Factor

Others

…

Biosimilars market, by Application:

Oncology

Blood Disorders

Growth Hormonal Deficiency

Chronic and Autoimmune Disorders

Others

…

Biosimilars Market Research Report 2014-2026, by region:

North America

The U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Latin America

Mexico

Brazil

Argentina

Pan Asia Pacific

China

Japan

South Korea

South East Asia Region

India

Australia

Middle East and Africa

Saudi Arabia

UAE

Qatar

Egypt

Nigeria

South Africa

Rest of MEA

The database is running updated by a group of research experts to always reflect the latest trends and information.

Table of Content

1. Introduction

1.1 Definition of the Market

1.2 Research Purpose

1.3 Scope of the Study

1.4 Stakeholders

1.5 Geography Coverage

1.6 Currency Under Consideration

1.7 Volume Units

1.8 Review Cycle

1.9 Summary and Key Findings of the Research

2 Research Methodology

2.1 Research Data

2.1.1 Secondary Data

2.1.2 Primary Data

2.2 Market Size Estimation

2.2.1 Bottom-Up Approach

2.2.2 Top-Down Approach (Involves time, Space, and Persons)

2.3 Data Triangulation

2.4 Assumptions

2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research

2.6 Limitations of Our Study

2.7 Scene Based Modeling

2.8 Covid-19 Impact/Evaluation

3. Market Dynamics

3.1 Driving Factors

3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

3.1.2 Increasing Use of Biosimilars by Different End-User/Applications

3.2 Restraints and Challenges in the Market

3.3 Opportunities

4. Global Biosimilars Market-Segmentation

4.1 By Type

4.1.1 Human Growth Hormone

4.1.2 Erythropoietin

4.1.3 Monoclonal Antibodies

4.1.4 Insulin

4.1.5 Interferon

4.1.6 Granulocyte-Colony Stimulating Factor

4.1.7 Others

4.2 By End-User/Application Industry

4.2.1 Oncology

4.2.2 Blood Disorders

4.2.3 Growth Hormonal Deficiency

4.2.4 Chronic and Autoimmune Disorders

4.2.5 Others

4.3 By Geography

4.3.1 North America Biosimilars Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.1.1 North America Biosimilars Production from 2014-2020

4.3.1.2 North America Biosimilars Consumption from 2014-2020

4.3.1.3 North America Biosimilars Import and Export from 2014-2020

4.3.1.4 North America Biosimilars Market Value ($) and Growth (%) by Type from 2019-2020

4.3.1.5 North America Biosimilars Market Value ($) and Growth (%) by Application from 2019-2020

4.3.1.6 North America Biosimilars Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.1.7 Top North America Biosimilars Participants Value ($) and Market Share (%) in 2019

4.3.2 Europe Biosimilars Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.2.1 Europe Biosimilars Production from 2014-2020

4.3.2.2 Europe Biosimilars Consumption from 2014-2020

4.3.2.3 Europe Biosimilars Import and Export from 2014-2020

4.3.2.4 Europe Biosimilars Market Value ($) and Growth (%) by Type from 2019-2020

4.3.2.5 Europe Biosimilars Value ($) and Growth (%) by Application from 2019-2020

4.3.2.6 Europe Biosimilars Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.2.7 Top Europe Biosimilars Participants Value ($) and Market Share (%) in 2019

4.3.3 Asia-Pacific Biosimilars Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.3.1 Asia-Pacific Biosimilars Production from 2014-2020

4.3.3.2 Asia-Pacific Biosimilars Consumption from 2014-2020

4.3.3.3 Asia-Pacific Biosimilars Import and Export from 2014-2020

4.3.3.4 Asia-Pacific Biosimilars Value ($) and Growth (%) by Type from 2019-2020

4.3.3.5 Asia-Pacific Biosimilars Value ($) and Growth (%) by Application from 2019-2020

4.3.3.6 Asia-Pacific Biosimilars Value ($) and Growth (%) by Countries from 2019-2020

4.3.3.7 Top Asia-Pacific Biosimilars Participants Value ($) and Market Share (%) in 2019

4.3.4 Latin America Biosimilars Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.4.1 Latin America Biosimilars Production from 2014-2020

4.3.4.2 Latin America Biosimilars Consumption from 2014-2020

4.3.4.3 Latin America Biosimilars Import and Export from 2014-2020

4.3.4.4 Latin America Biosimilars Value ($) and Growth (%) by Type from 2019-2020

4.3.4.5 Latin America Biosimilars Value ($) and Growth (%) by Application from 2019-2020

4.3.4.6 Latin America Biosimilars Value ($) and Growth (%) by Countries from 2019-2020

4.3.4.7 Top Latin America Biosimilars Participants Value ($) and Market Share (%) in 2019

4.3.5 Middle East & Africa Biosimilars Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.5.1 Middle East & Africa Biosimilars Production from 2014-2020

4.3.5.2 Middle East & Africa Biosimilars Consumption from 2014-2020

4.3.5.3 Middle East & Africa Biosimilars Import and Export from 2014-2020

4.3.5.4 Middle East & Africa Biosimilars Value ($) and Growth (%) by Type from 2019-2020

4.3.5.5 Middle East & Africa Biosimilars Value ($) and Growth (%) by Application from 2019-2020

4.3.5.6 Middle East & Africa Biosimilars Value ($) and Growth (%) by Countries from 2019-2020

4.3.5.7 Top Middle East & Africa Biosimilars Participants Value ($) and Market Share (%) in 2019

5. Competitive Intelligence – Company Profiles

5.1 Amgen Inc

5.1.1 Amgen Inc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.1.2 Amgen Inc Sales, Growth Rate and Global Market Share from 2014-2020

5.2 Teva Pharmaceutical Industries Ltd.

5.2.1 Teva Pharmaceutical Industries Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.2.2 Teva Pharmaceutical Industries Ltd. Sales, Growth Rate and Global Market Share from 2014-2020

5.3 Mylan N.V

5.3.1 Mylan N.V Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.3.2 Mylan N.V Sales, Growth Rate and Global Market Share from 2014-2020

5.4 Sandoz International GmbH

5.4.1 Sandoz International GmbH Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.4.2 Sandoz International GmbH Sales, Growth Rate and Global Market Share from 2014-2020

5.5 Dr. Reddy’s Laboratories Ltd.

5.5.1 Dr. Reddy’s Laboratories Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.5.2 Dr. Reddy’s Laboratories Ltd. Sales, Growth Rate and Global Market Share from 2014-2020

5.6 Samsung Bioepis

5.6.1 Samsung Bioepis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.6.2 Samsung Bioepis Sales, Growth Rate and Global Market Share from 2014-2020

5.7 Biocon

5.7.1 Biocon Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.7.2 Biocon Sales, Growth Rate and Global Market Share from 2014-2020

5.8 F. Hoffmann-La Roche AG

5.8.1 F. Hoffmann-La Roche AG Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.8.2 F. Hoffmann-La Roche AG Sales, Growth Rate and Global Market Share from 2014-2020

5.9 Pfizer Inc.

5.9.1 Pfizer Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.9.2 Pfizer Inc. Sales, Growth Rate and Global Market Share from 2014-2020

6. Investment Analysis

6.1 Fundamental Analysis (Porter's Five Forces Analysis)

6.2 Technical Preparation Analysis

6.3 Risk Evaluating Analysis

6.4 Estimated Investment Pay-Back Period

7. Future Forecast of the Global Biosimilars Market from 2021-2026

7.1 Future Forecast of Global Biosimilars Market from 2021-2026 Segment by Region

7.2 Future Forecast of the Global Biosimilars Market from 2021-2026 Segment by Types

7.3 Future Forecast of the Global Biosimilars Market from 2021-2026 Segment by End-User/Applications

8 Appendix

8.1 Discussion Guide

8.2 Related Reports

8.3 Author List

9 Disclaimer

List of Tables and Figures

Global Biosimilars Market Value ($) and Growth Rate of Biosimilars from 2014-2026

Global Biosimilars Production and Growth Rate Segment by Product Types from 2014-2026F

Global Biosimilars Consumption and Growth Rate Segment by End-User/Application from 2014-2026E

Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)

Table Global Biosimilars Production and Growth Rate Segment by Product Types from 2014-2020

Table Global Biosimilars Value ($) and Growth Rate Segment by Product Types from 2014-2020

Figure Human Growth Hormone of Biosimilars

Figure Erythropoietin of Biosimilars

Figure Monoclonal Antibodies of Biosimilars

Figure Insulin of Biosimilars

Figure Interferon of Biosimilars

Figure Granulocyte-Colony Stimulating Factor of Biosimilars

Figure Others of Biosimilars

Table Global Biosimilars Consumption and Growth Rate Segment by End-User/Application from 2014-2020

Table Global Biosimilars Value ($) and Growth Rate Segment by End-User/Application from 2014-2020

Figure Oncology of Biosimilars

Figure Blood Disorders of Biosimilars

Figure Growth Hormonal Deficiency of Biosimilars

Figure Chronic and Autoimmune Disorders of Biosimilars

Figure Others of Biosimilars

Table Global Biosimilars Production Value ($) by Regions

Table Global Biosimilars Production Value Share by Regions

Table Global Biosimilars Production by Regions

Table Global Biosimilars Production Share by Regions

Table Global Biosimilars Consumption by Regions

Table Global Biosimilars Consumption Share by Regions

Figure North America Biosimilars Production and Growth Rate from 2014-2020

Figure North America Biosimilars Consumption and Growth Rate from 2014-2020

Table North America Biosimilars Import and Export from 2014-2020

Table North America Biosimilars Value ($) and Growth (%) by Type from 2019-2020

Table North America Biosimilars Value ($) and Growth (%) by Application from 2019-2020

Table North America Biosimilars Value ($) and Growth (%) by Countries from 2019-2020

Table Top North America Biosimilars Participants Value ($) and Market Share (%) in 2019

Figure Europe Biosimilars Production and Growth Rate from 2014-2020

Figure Europe Biosimilars Consumption and Growth Rate from 2014-2020

Table Europe Biosimilars Import and Export from 2014-2020

Table Europe Biosimilars Value ($) and Growth (%) by Type from 2019-2020

Table Europe Biosimilars Value ($) and Growth (%) by Application from 2019-2020

Table Europe Biosimilars Market Value ($) and Growth (%) by Countries from 2019-2020

Table Top Europe Biosimilars Participants Value ($) and Market Share (%) in 2019

Figure Asia-Pacific Biosimilars Production and Growth Rate from 2014-2020

Figure Asia-Pacific Biosimilars Consumption and Growth Rate from 2014-2020

Table Asia-Pacific Biosimilars Import and Export from 2014-2020

Table Asia-Pacific Biosimilars Value ($) and Growth (%) by Type from 2019-2020

Table Asia-Pacific Biosimilars Value ($) and Growth (%) by Application from 2019-2020

Table Asia-Pacific Biosimilars Value ($) and Growth (%) by Countries from 2019-2020

Table Top Asia-Pacific Biosimilars Participants Value ($) and Market Share (%) in 2019

Figure Latin America Biosimilars Production and Growth Rate from 2014-2020

Figure Latin America Biosimilars Consumption and Growth Rate from 2014-2020

Table Latin America Biosimilars Import and Export from 2014-2020

Table Latin America Biosimilars Value ($) and Growth (%) by Type from 2019-2020

Table Latin America Biosimilars Value ($) and Growth (%) by Application from 2019-2020

Table Latin America Biosimilars Value ($) and Growth (%) by Countries from 2019-2020

Table Top Latin America Biosimilars Participants Value ($) and Market Share (%) in 2019

Figure Middle East & Africa Biosimilars Production and Growth Rate from 2014-2020

Figure Middle East & Africa Biosimilars Consumption and Growth Rate from 2014-2020

Table Middle East & Africa Biosimilars Import and Export from 2014-2020

Table Middle East & Africa Biosimilars Value ($) and Growth (%) by Type from 2019-2020

Table Middle East & Africa Biosimilars Value ($) and Growth (%) by Application from 2019-2020

Table Middle East & Africa Biosimilars Value ($) and Growth (%) by Countries from 2019-2020

Table Top Middle East & Africa Biosimilars Participants Value ($) and Market Share (%) in 2019

Table Amgen Inc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Amgen Inc Sales and Growth Rate from 2014-2020

Figure Amgen Inc Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Teva Pharmaceutical Industries Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Teva Pharmaceutical Industries Ltd. Sales and Growth Rate from 2014-2020

Figure Teva Pharmaceutical Industries Ltd. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Mylan N.V Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Mylan N.V Sales and Growth Rate from 2014-2020

Figure Mylan N.V Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Sandoz International GmbH Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Sandoz International GmbH Sales and Growth Rate from 2014-2020

Figure Sandoz International GmbH Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Dr. Reddy’s Laboratories Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Dr. Reddy’s Laboratories Ltd. Sales and Growth Rate from 2014-2020

Figure Dr. Reddy’s Laboratories Ltd. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Samsung Bioepis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Samsung Bioepis Sales and Growth Rate from 2014-2020

Figure Samsung Bioepis Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Biocon Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Biocon Sales and Growth Rate from 2014-2020

Figure Biocon Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table F. Hoffmann-La Roche AG Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure F. Hoffmann-La Roche AG Sales and Growth Rate from 2014-2020

Figure F. Hoffmann-La Roche AG Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Pfizer Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Pfizer Inc. Sales and Growth Rate from 2014-2020

Figure Pfizer Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Global Biosimilars Value ($) and Growth Rate Forecast by Regions (2021-2026)

Table Global Biosimilars Production and Growth Rate Forecast by Regions (2021-2026)

Table Global Biosimilars Consumption and Growth Rate Forecast by Regions (2021-2026)

Table Global Biosimilars Production and Growth Rate Forecast by Types (2021-2026)

Table Global Biosimilars Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390